VERA
Vera Therapeutics, Inc.
Next earnings Aug 3, 2026 · consensus $-1.63 EPS
Last earnings -2.0% on 2026-05-07
$38.20
▼ -0.60%$38.20▲ +80.61%
over 1Y
L $19.25EODHDH $55.67
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.6%
1W+13.5%
1M+11.2%
3M-3.9%
YTD-21.4%
1Y+80.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy
Conservative balance sheet (liabilities/equity 0.22x).
Vera Therapeutics, Inc. shows limited reported revenue, and -49.6% ROE.
Sources: SEC EDGAR (CIK 0001831828, latest 10-Q filed 2026-05-07) · EODHD · as of 6/24/2026, 12:23:33 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.